Commentary
The overdiagnosis theory in lung cancer screening: Does it make any sense?
First published: 19 November 2013
No abstract is available for this article.
REFERENCES
- 1
Strauss GM,
Dominioni L:
Chest X-ray screening for lung cancer: Overdiagnosis, endpoints, and randomized population trials.
J Surg Oncol
2013;
108: 294–300.
- 2
Jacobson FL,
Jaklitsch MT:
Low-dose CT screening for lung cancer: The time is now.
J Surg Oncol
2013;
108: 265–269.
- 3
Strauss GM,
Dominioni L:
Perception, paradox, paradigm: Alice in the wonderland of lung cancer prevention and early detection.
Cancer
2000;
89: 2422–2431.
- 4
Bach PB:
Overdiagnosis in lung cancer: Different perspectives, definitions, implications.
Thorax
2008;
63: 298–300.
- 5
Sox HC:
Screening for lung cancer with chest radiographs.
JAMA
2011;
306: 1916–1918.
- 6
Gabriel PH,
Delongchamps N:
Brawley O: et al:
The worldwide epidemiology of prostate cancer: Perspective from autopsy studies.
Can J Urol
2008;
15: 3866–3871.
- 7
Manser RL,
Dodd M,
Byrnes G: et al:
Incidental lung cancers identified at coronial autopsy: Implications for overdiagnosis of lung cancer by screening.
Respir Med
2005;
99: 501–507.
- 8
Penney KL,
Stampfer MJ,
Jahn JL:
Gleason grade progression is uncommon.
Cancer Res
2013;
73: 5163–5168.
- 9
The National Lung Screening Trial Research Team: Reduced lung-cancer mortality with low-dose computed tomographic screening.
N Engl J Med
2011;
365: 395–409.
- 10
Sox HC:
Better evidence about screening for lung cancer.
N Engl J Med
2011;
365: 455–457.
